Wyden Statement on Tax Avoidance Strategies Reportedly Used by Donald Trump
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement after reports that Donald Trump used legally-dubious strategies to dodge taxes in the early 1990s: “Every story that comes out about Donald Trump’s reported tax dodging and ties to Russia is a fresh reminder of the outrageous fact that he is refusing […]
Leahy, Wyden Alarmed By Decreased DEA Enforcement Of Pharmaceutical Distributors
WASHINGTON – Senate Judiciary Committee Ranking Member Patrick Leahy, D-Vt., and Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today sent a letter to Attorney General Loretta Lynch following reports published by the Washington Post concerning the Justice Department’s oversight of major pharmaceutical distributors that dispense opioid-based pain drugs . The reports detail the slowdown […]
Wyden Looks To Tighten Sanctions On Syria
WASHINGTON – In an effort to investigate ways the U.S. could further isolate the government of Bashar al Assad and pressure him to end his campaign of violence against his own nation, Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) today requested detailed information from the Treasury Department on sanctions in place against the Syrian […]
Wyden, Crapo Call for Fairness for U.S. Jobs and Rural Communities in Softwood Lumber Deal
WASHINGTON — In a letter sent to President Barack Obama today, Senate Finance Committee Ranking Member Ron Wyden, D-Ore., Senator Mike Crapo, R-Idaho, and 22 other Senators called for any new softwood lumber agreement with Canada to protect U.S. timber jobs and communities. “Hundreds of thousands of U.S. jobs and thousands of U.S. rural communities […]
Wyden Kicks Off Inquiry To Test Disclosure Laws For Shell Companies
WASHINGTON – In an effort to assess the effectiveness of federal disclosure requirements intended to fight the misuse use of shell companies, Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) today sent a letter to the heads of the Treasury Department and IRS requesting detailed reports on filings by the thousands of firms linked to […]
Wyden Statement on 2017 COLA and Medicare Part B Premiums
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued a statement following the announcement of a 0.3 percent Cost of Living Adjustment (COLA) increase in 2017. The increase is expected to raise premiums significantly for some in Medicare Part B. “Seniors in Medicare expect their health costs to be affordable and stable, and I’ll […]
Wyden Statement on Section 385 Regulations
Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) today issued the following statement on Section 385 regulations issued by the Treasury Department: “These final rules on Section 385 clearly reflect a lot of input and careful study, and in my view they will go a long way to protecting our corporate tax base. What this […]
Wyden Statement On End Of US-Canada Softwood Lumber Standstill Period
WASHINGTON — Senate Finance Committee Ranking Member Ron Wyden, D-Ore., issued the following statement on efforts to resolve longstanding differences between the United States and Canada over subsidies to Canadian lumber production. A one-year pause on filing new trade cases over softwood subsidies ends at midnight tonight. “Unless Canada can fulfill the principles agreed to […]
Wyden Report: Opioid Funds Lacking, Nationwide Epidemic Will Continue to Rage
WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today released a report outlining the consequences of underfunding treatment for opioid addiction, now an epidemic across the United States. Earlier this year, Congress passed the Comprehensive Addiction and Recovery Act of 2016 (CARA), but provided no funds to the policies it authorized. Additionally, Congress […]
Wyden Statement on Mylan Settlement
Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) today issued the statement below following news that Mylan NV will pay $465 million to the Department of Justice and other agencies to settle the question of whether the company had for years been vastly underpaying EpiPen rebates owed to Medicaid. “Today’s news is a first step […]